Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

Abstract Introduction This article aims to describe malignancies in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), or non-radiographic axial spondyloarthritis (nr-axSpA) treated with upadacitinib (UPA) or active comparators. Methods This integrated s...

Полное описание

Библиографические подробности
Главные авторы:	Andrea Rubbert-Roth, Adriana M. Kakehasi, Tsutomu Takeuchi, Marc Schmalzing, Hannah Palac, Derek Coombs, Jianzhong Liu, Samuel I. Anyanwu, Ralph Lippe, Jeffrey R. Curtis
Формат:	Статья
Язык:	English
Опубликовано:	Adis, Springer Healthcare 2023-11-01
Серии:	Rheumatology and Therapy
Предметы:	Ankylosing spondylitis (AS) Janus kinase (JAK) inhibitor Malignancy Nonmelanoma skin cancer (NMSC) Non-radiographic axial spondyloarthritis (nr-axSpA) Psoriatic arthritis (PsA)
Online-ссылка:	https://doi.org/10.1007/s40744-023-00621-6

Схожие документы

Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis
по: Natalie Frede, и др.
Опубликовано: (2022-10-01)

Treat to Target in Spondyloarthritis: Myth or Reality?
по: Nelly Ziade, и др.
Опубликовано: (2021-07-01)

Two-year imaging outcomes from a phase 3 randomized trial of secukinumab in patients with non-radiographic axial spondyloarthritis
по: Juergen Braun, и др.
Опубликовано: (2023-05-01)

Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis
по: Jonas Sagard, и др.
Опубликовано: (2022-02-01)

Antibodies of the immunoglobulin a isotype to novel antigens in early axial spondyloarthritis
по: Pieter Ruytinx, и др.
Опубликовано: (2023-02-01)

Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study
по: M. Lorenzin, и др.
Опубликовано: (2017-08-01)

Axial Spondyloarthritis: An Evolving Concept
по: Nelly Ziadé
Опубликовано: (2015-07-01)

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
по: Gerd R. Burmester, и др.
Опубликовано: (2024-04-01)

Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
по: Roberta Ramonda, и др.
Опубликовано: (2024-07-01)

Cinematic rendering in rheumatic diseases—Photorealistic depiction of pathologies improves disease understanding for patients
по: Milena L. Pachowsky, и др.
Опубликовано: (2022-08-01)

Comparison of Clinical Features in HLA-B27 Positive and Negative Patients With Axial Spondyloarthritis: Results From a Cohort of 4,131 Patients
по: Shangzhu Zhang, и др.
Опубликовано: (2020-12-01)

Dual-Energy-CT for Osteitis and Fat Lesions in Axial Spondyloarthritis: How Feasible Is Low-Dose Scanning?
по: Dominik Deppe, и др.
Опубликовано: (2023-02-01)

Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota
по: Tejpal Gill, и др.
Опубликовано: (2022-09-01)

Qualitative concept elicitation and cognitive debriefing interviews of symptoms, impacts and selected customized PROMIS® Short Forms: a study in patients with axial spondyloarthritis
по: Amy Findley, и др.
Опубликовано: (2023-04-01)

Axial Spondyloarthritis in the Era of Precision Medicine: Biomarkers, Microbiota, and Multimodal Therapy
по: Karolina Kopeć, и др.
Опубликовано: (2025-03-01)

A UK Best Practice Model for Diagnosis and Treatment of Axial Spondyloarthritis
по: Rebecca Adshead, и др.
Опубликовано: (2015-07-01)

Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
по: Cristina Valero-Martínez, и др.
Опубликовано: (2023-10-01)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
по: Diego Benavent, и др.
Опубликовано: (2023-02-01)

Upadacitinib for the treatment of psoriatic arthritis
по: Diogo Fonseca, и др.
Опубликовано: (2023-02-01)

The Role of Vitamin D in Disease Activity in Axial Spondyloarthritis
по: Geraint Alun Brown, и др.
Опубликовано: (2020-07-01)

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
по: Peter Nash, и др.
Опубликовано: (2018-11-01)

Editorial: Pathophysiology of bone and mineral metabolism
по: Elena Ambrogini, и др.
Опубликовано: (2024-02-01)

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
по: Karin Bengtsson, и др.
Опубликовано: (2017-05-01)

Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
по: Е. Е. Gubar, и др.
Опубликовано: (2024-04-01)

Are TNF-α and IL-1β Independently Associated with Depression in Axial Spondyloarthritis Patients? A Case-Control Study
по: Md. Nazrul Islam, и др.
Опубликовано: (2024-01-01)

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study
по: Iain B. McInnes, и др.
Опубликовано: (2022-10-01)

Axial Spondyloarthritis: Clinical Characteristics, Epidemiology, and General Approaches to Management
по: Conall MacGearailt, и др.
Опубликовано: (2021-07-01)

Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data
по: Raquel Ena María Granados, и др.
Опубликовано: (2023-06-01)

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
по: Matthias Jarlborg, и др.
Опубликовано: (2020-05-01)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
по: Sara Alonso, и др.
Опубликовано: (2021-05-01)

Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies
по: Xenofon Baraliakos, и др.
Опубликовано: (2023-04-01)

Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
по: Jiao Wang, и др.
Опубликовано: (2025-02-01)

Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort Study
по: Annalisa Marino, и др.
Опубликовано: (2024-02-01)

Monosodium urate crystal deposition associated with the progress of radiographic grade at the sacroiliac joint in axial SpA: a dual-energy CT study
по: Junqing Zhu, и др.
Опубликовано: (2017-05-01)

Zero echo time MRI improved detection of erosions and sclerosis in the sacroiliac joint in comparison with LAVA-flex
по: Churong Lin, и др.
Опубликовано: (2023-05-01)

Psoriatic arthritis with atypical manifestations
по: Ivna Tomaš, и др.
Опубликовано: (2023-01-01)

Etanercept in axial spondyloarthritis – treatment efficacy
по: I. Z. Gaydukova, и др.
Опубликовано: (2022-03-01)

Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data
по: Ian C. Scott, и др.
Опубликовано: (2022-12-01)

A case of rheumatoid spondyloarthritis!
по: Sujatha N, и др.
Опубликовано: (2019-01-01)

Effectiveness and safety of secukinumab in axial spondyloarthritis and psoriatic arthritis: A retrospective analysis of its real-world usage from India
по: Sham Santhanam, и др.
Опубликовано: (2020-01-01)